DEERFIELD BEACH, Fla., Nov. 30, 2015 /PRNewswire/ -- BIOCLAIM announced today that is has been selected as a finalist in this year's Fierce Innovation Awards: Healthcare Edition, an awards program from the publisher of FierceHealthIT, FierceHealthcare, and FierceMobileHealthcare. BIOCLAIM was recognized as a finalist in the category of "Privacy and Cybersecurity."
BIOCLAIM was also named as a finalist in this year's Fierce Innovation Awards: Payer Edition, an awards program from the publisher of FierceHealthPayerand FierceHealthcare in the category of "Fraud and Abuse Detection/Prevention."
Finalists were selected by a distinguished panel of CIOs from renowned U.S. hospitals and healthcare systems, including Allina Health, Rush University Medical Center, Aspirus, and JFK Health System, among others. A complete list of judges can be found at https://www.fierceinnovationawards.com/healthit/2015#our_judges.
All applications were evaluated based on the following criteria: care efficiency, competitive advantage, financial impact/value, market need, patient experience/satisfaction, quality of care and patient outcomes, and overall fierceness and innovation. Finalists were selected based on calculation of the judges' scores in each area.
"We are grateful to the distinguished panel who recognized the need for BIOCLAIM to protect and safeguard health care data," said Scott Kimmel, General Counsel for BIOCLAIM.
BIOCLAIM is a multi-patented software solution that uses biometric technology such as SRI's IOM tablet or RightPatient™ to eliminate the largest types of health care fraud while protecting patients and providers from Medical Identity Theft. BIOCLAIM is the only solution that can communicate the biometric record created at the point of service to the payer thereby eliminating phantom billing fraud.
To learn more about BIOCLAIM, visit www.BIOCLAIM.com